Date: 9/11/2009
Sponsor: Dana Farber Cancer Institute
Physician: Steven Treon, MD, PhD

The purpose of this research study is to determine the safety of RAD001(Everolimus) and the highest dose of this drug that can be given to people safely. RAD001(Everolimus) is a drug that works by preventing cells in the body from growing and dividing. Information from basic and Phase I clinical research studies suggests that RAD001 also may help to prevent tumor growth in people with relapsed or refractory lymphoma.

For more information about this clinical trial, please visit www.clinicaltrials.gov.